Second, a series of in vitro and in vivo experiments using TUSC3 KD and/or KO cells consistently showed that TUSC3 deficiency enhanced the metastatic potential of NSCLC (Fig. 2 and Supplementary Fig. 2, 3). This evidence concerns the gene TUSC3 and non-small cell lung carcinoma.